Abstract:For our objectives to find ways of improving poor drug absorption from intestine, the active absorption of glucose and galactose by the glucose transport system in the intestne was so attractive that an effect of conjugating sugar to the drugs on its intestinal absorption was studied. After absorption of 2-naphthyl α-glucoside (2-NAαglc), the major costituents appearing on the serosal side were 2-naphthol (2-NA) and its glucuronide. Meanwhile, after absorption of 2-naphthyl β-glucoside (2-NAβglc), the major constituents appearing on the serosal side were 2-NAβglc and 2-NA glucuronide. The total (glycoside + aglycone + glucuronide) absorption of 2-NAβglc and 2-NAαglc was significantly (P<0.05) decreased in the absence of Na+, indicating the active absorption of glucosides of 2-NA by the Na+-dependent glucose transport carrier (GTC). After absorption of 1-naphthyl α-galactoside (1-NAαgal) and 1-naphthyl β-galactoside (1-NAβgal), on the other hand, the major constitute appearing on the serosal side was 1-NAαgal and 1-NAβgal, respectively. A significant contribution of the GTC was observed in 1-NAβgal absorption, but not in 1-NAαgal absorption. Na+-dependent total absorption of 2-NAβglc was equivalent to that of 2-NAαglc, and was larger than that of 2-NAβgal. Na+-dependent total absorption of 1-NAβgal was larger than that of 1-NAαgal. These results, which were similar to those of p-nitrophenyl glycosides (1, 2), indicated that glucose conjugation was more effective on the active absorption by glucose transport carrier than galactose conjugation. These results were developed to the design of sugar-conjugated tripeptide (Tyrosine-Glycine-Glycine, TGG). β-Glucose-conjugated TGG with a spacer (βglc-spacer-TGG) was transported to the serosal side, and any of the other compounds such as TGG were not determined. α-Glucose-conjugated TGG with a spacer (αglc-spacer-TGG) was also transported to the serosal side but a few amount of the desglucosylated compound (TGG possessing only spacer, spacer-TGG) was detected. However, spacer-TGG was transported to the serosal side more than β or αglc-spacer-TGG. Moreover, although the absorption of βglc-spacer-TGG, αglc-spacer-TGG and spacer-TGG were shown to be dependent on Na+, competitive inhibition was not observed in the absorption between βglc-spacer-TGG and spacer-TGG, indicating a contribution of a transport carrier to the absorption was unclear. Since TGG was not transported to the serosal side and about 80% of TGG on the mucosal side was degraded after 20min, these modification of TGG were indicated to protect TGG from degradation, at least, through the intestinal membrane.

Improvement of pulmonary absorptions of poorly absorbable drugs using Gelucire 44/14 as an absorption enhancer

Gelucire44/14 as a novel absorption enhancer for drugs with different hydrophilicities: in vitro and in vivo improvement on transcorneal permeation

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Comparing The Enhancement Efficiency Between Liposomes And Microbubbles For Insulin Pulmonary Absorption

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs

Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles

The Passive Diffusion Improvement of Vitamin B 12 Intestinal Absorption by Gelucire that fit for Commercialized Production

Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.

Sulfobetaine modification of poly (D, L-lactide-co-glycolic acid) nanoparticles enhances mucus permeability and improves bioavailability of orally delivered liraglutide

Sublingual Delivery of Insulin: Effects of Enhancers on the Mucosal Lipid Fluidity and Protein Conformation, Transport, and in Vivo Hypoglycemic Activity

Improved Dissolution and Solubility Characteristics of Clopidogrel Bisulphate using Gelucire 44/14

Effect of Absorption Enhancers on Nasal Delivery of Basic Fibroblast Growth Factor

Enhanced Oral Absorption of Icaritin by Using Mixed Polymeric Micelles Prepared with a Creative Acid-Base Shift Method

Enhanced Cellular Delivery of Tildipirosin by Xanthan Gum-Gelatin Composite Nanogels

Improvement of intestinal transport of poorly absorbed drugs by sugar conjugation

Transforming canagliflozin solubility using lipidic carrier and its pharmacokinetic study

Molecular insights into the aggregation and solubilizing behavior of biocompatible amphiphiles Gelucire® 48/16 and Tetronics® 1304 in aqueous media

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

Artificial Pulmonary Surfactant As A Carrier for Intratracheally Instilled Insulin

Improving Drug Utilization Platform with Injectable Mucoadhesive Hydrogel for Treating Ulcerative Colitis